UBS Group AG - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X309. A total of 13 filers reported holding BIOPHARMX CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2020$11,000
+120.0%
34,821
+204.6%
0.00%
Q4 2019$5,000
+400.0%
11,433
+259.3%
0.00%
Q3 2019$1,000
-92.9%
3,182
-86.1%
0.00%
Q2 2019$14,00022,8460.00%
Other shareholders
BIOPHARMX CORP shareholders Q1 2020
NameSharesValueWeighting ↓
BARCLAYS PLC 121,823$37,0000.00%
VANGUARD GROUP INC 74,852$23,0000.00%
Advisory Services Network, LLC 60$00.00%
VICTORY CAPITAL MANAGEMENT INC 4,538$2,0000.00%
UBS Group AG 34,821$11,0000.00%
BANK OF AMERICA CORP /DE/ 11,000$3,0000.00%
WELLS FARGO & COMPANY/MN 102$00.00%
NORTHERN TRUST CORP 22,001$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,866$8,0000.00%
View complete list of BIOPHARMX CORP shareholders